SARS-CoV-2 vaccine safety in adolescents with inflammatory rheumatic and musculoskeletal diseases and adults with juvenile idiopathic arthritis: data from the EULAR COVAX physician-reported registry

Lawson‐Tovey, Saskia; Machado, Pedro; Strangfeld, Anja; F Mateus, Elsa; Gossec, Laure; Carmona, Loreto; Raffeiner, Bernd; Buliņa, Inita; Clemente, Daniel; Zepa, Jūlija; Maria Rodrigues, Ana; Mariette, Xavier; L Hyrich, Kimme

doi:10.1136/rmdopen-2022-002322

Public

SARS-CoV-2 vaccine safety in adolescents with inflammatory rheumatic and musculoskeletal diseases and adults with juvenile idiopathic arthritis: data from the EULAR COVAX physician-reported registry

Published in RMD Open • Jul 1, 2022

Authors:

Saskia Lawson‐Tovey

Pedro Machado

Anja Strangfeld

Abstract

BACKGROUND: There is a lack of data on SARS-CoV-2 vaccination safety in children and young people (CYP) with rheumatic and musculoskeletal diseases (RMDs). Current vaccination guidance is based on data from adults with RMDs or CYP without RMDs. OBJECTIVES: To describe the safety of SARS-COV-2 vaccin...

Subject

Medicine

Arthritis

Vaccination

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!